Yahoo Finance

Estimated Discount To Fair Value: 39.3%

BlueNord ASA, trading at NOK664, is significantly below its estimated fair value of NOK1094.56, indicating it is undervalued based on cash flows. Despite a recent net loss of US$70.8 million for 2024 and interest payments not well covered by earnings, the company is forecast to achieve high profitability growth over the next three years. Recent operational challenges at Tyra II are expected to be resolved soon, potentially enhancing production efficiency and financial performance going forward.

• Our earnings growth report unveils the potential for significant increases in BlueNord's future results.

• Click to explore a detailed breakdown of our findings in BlueNord's balance sheet health report.

Bonesupport Holding

Overview: Bonesupport Holding AB (publ) is an orthobiologics company that develops and commercializes injectable bio-ceramic bone graft substitutes across Europe, North America, and internationally, with a market cap of SEK21.85 billion.

Operations: The company's revenue primarily comes from its Pharmaceuticals segment, generating SEK898.73 million.

Estimated Discount To Fair Value: 42.8%

Bonesupport Holding, trading at SEK331.8, is significantly undervalued with an estimated fair value of SEK580.34 based on cash flow analysis. Despite a decrease in net profit margin from 41.5% to 14.9% over the past year, its earnings and revenue are forecast to grow substantially faster than the Swedish market over the next three years. Recent positive study results for CERAMENT products may bolster future growth prospects and enhance profitability further.

• Upon reviewing our latest growth report, Bonesupport Holding's projected financial performance appears quite optimistic.

• Unlock comprehensive insights into our analysis of Bonesupport Holding stock in this financial health report.

Seize The Opportunity

• Click through to start exploring the rest of the 209 Undervalued European Stocks Based On Cash Flows now.

• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.

• Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.

Ready For A Different Approach?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ENXTLS:ALTR OB:BNOR and OM:BONEX.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com